Artemether/Lumefantrine and Vivax Malaria

• Status: Completed
• Trial end date: 2012-09-01
• Target enrollment: 0
• Participant gender: All

Summary

The cure rate of artemether/lumefantrine in the treatment of vivax malaria.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University of Khartoum
• Collaborator: University of Kassala, Sudan
• Treatments: Artemether; Artemether-lumefantrine combination; Artemether, Lumefantrine Drug Combination; Artemisinins; Lumefantrine

Criteria

Inclusion Criteria:

• Patients with vivax malaria

Exclusion Criteria:

• severe malaria

• pregnancy